色甘酸钠与β-2-激动剂联合治疗特应性支气管哮喘患者的临床评估（初步研究）
[Clinical evaluation of disodium cromoglycate with beta-2-agonist in therapy of patients with atopic bronchial asthma (preliminary study)].
作者信息
Płusa T, Mamełka B, Chciałowski A, Włodarczyk R
机构信息
II Kliniki Chorób Wewnetrznych Instytutu Medycyny Wewnetrznej Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej, Warszawie.
出版信息
Pneumonol Alergol Pol. 1993;61(3-4):183-8.
In 38 patients with atopic bronchial asthma DNCG (disodium cromoglycate) and DNCG comp. (disodium cromoglycate and reproterol hydrochloride) were applied in inhalation way. After 7 days course spirometric values were monitoring in all patients. Decrease of Raw values and increases of FEF50 and FEV1 were noticed in all patients, especially in asthmatics treated with DNCG comp. Obtained results suggest a good clinical effect and improvement of spirometric values in patients with atopic bronchial asthma during DNCG and DNCG comp. therapy.
在38例特应性支气管哮喘患者中，采用吸入方式应用色甘酸钠（DNCG）和复方色甘酸钠（色甘酸钠与盐酸丙卡特罗）。疗程7天后，对所有患者进行肺功能监测。所有患者均出现气道阻力（Raw）值降低，50%用力呼气流量（FEF50）和第1秒用力呼气容积（FEV1）升高，尤其是使用复方色甘酸钠治疗的哮喘患者。所得结果表明，色甘酸钠和复方色甘酸钠治疗特应性支气管哮喘患者具有良好的临床效果，并能改善肺功能指标。
Zotero 插件